Sadaf Pakdaman

411 total citations
14 papers, 222 citations indexed

About

Sadaf Pakdaman is a scholar working on Hematology, Genetics and Physiology. According to data from OpenAlex, Sadaf Pakdaman has authored 14 papers receiving a total of 222 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 9 papers in Genetics and 7 papers in Physiology. Recurrent topics in Sadaf Pakdaman's work include Blood groups and transfusion (13 papers), Hemoglobinopathies and Related Disorders (9 papers) and Erythrocyte Function and Pathophysiology (7 papers). Sadaf Pakdaman is often cited by papers focused on Blood groups and transfusion (13 papers), Hemoglobinopathies and Related Disorders (9 papers) and Erythrocyte Function and Pathophysiology (7 papers). Sadaf Pakdaman collaborates with scholars based in France, Netherlands and United States. Sadaf Pakdaman's co-authors include Frédéric Galactéros, France Pirenne, Benoît Vingert, Marie Tamagne, Anoosha Habibi, Pablo Bartolucci, Philippe Bierling, F. Noizat‐Pirenne, Philippe Chadebech and Gwellaouen Bodivit and has published in prestigious journals such as Blood, Frontiers in Immunology and European Journal of Immunology.

In The Last Decade

Sadaf Pakdaman

14 papers receiving 222 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sadaf Pakdaman France 8 168 149 110 25 23 14 222
Robert Mignacca United States 4 331 2.0× 269 1.8× 230 2.1× 7 0.3× 11 0.5× 4 358
Olufolake Adisa United States 6 194 1.2× 272 1.8× 113 1.0× 20 0.8× 146 6.3× 15 369
Corrado Masciullo Italy 6 162 1.0× 124 0.8× 22 0.2× 10 0.4× 23 1.0× 9 299
Marlene Allman United Kingdom 6 115 0.7× 127 0.9× 23 0.2× 5 0.2× 21 0.9× 8 174
Johara Hassan United States 4 146 0.9× 190 1.3× 21 0.2× 8 0.3× 32 1.4× 10 222
Tania Robe-Rybkine France 4 63 0.4× 57 0.4× 33 0.3× 88 3.5× 51 2.2× 5 189
Hiraku Mori Japan 9 144 0.9× 91 0.6× 12 0.1× 11 0.4× 59 2.6× 23 219
R. Parra Spain 12 273 1.6× 61 0.4× 28 0.3× 3 0.1× 43 1.9× 21 299
Shane Grimsley United Kingdom 6 85 0.5× 38 0.3× 66 0.6× 2 0.1× 14 0.6× 6 117
Supachai Ekwattanakit Thailand 6 212 1.3× 254 1.7× 94 0.9× 4 0.2× 57 2.5× 21 326

Countries citing papers authored by Sadaf Pakdaman

Since Specialization
Citations

This map shows the geographic impact of Sadaf Pakdaman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sadaf Pakdaman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sadaf Pakdaman more than expected).

Fields of papers citing papers by Sadaf Pakdaman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sadaf Pakdaman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sadaf Pakdaman. The network helps show where Sadaf Pakdaman may publish in the future.

Co-authorship network of co-authors of Sadaf Pakdaman

This figure shows the co-authorship network connecting the top 25 collaborators of Sadaf Pakdaman. A scholar is included among the top collaborators of Sadaf Pakdaman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sadaf Pakdaman. Sadaf Pakdaman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Malard, Lucile, Sadaf Pakdaman, Anoosha Habibi, et al.. (2023). Eleven years of alloimmunization in 6496 patients with sickle cell disease in France who received transfusion. Blood Advances. 7(24). 7608–7620. 7 indexed citations
2.
Nguyen, Kim‐Anh, Philippe Chadebech, Gwellaouen Bodivit, et al.. (2022). Preclinical evaluation of the preservation of red blood cell concentrates by hypoxic storage technology for transfusion in sickle cell disease. Haematologica. 107(8). 1944–1949. 3 indexed citations
3.
Tamagne, Marie, et al.. (2022). Autologous blood extracellular vesicles and specific CD4+ T-cell co-activation. Frontiers in Immunology. 13. 992483–992483. 7 indexed citations
4.
Vasseur, Corinne, et al.. (2021). Alpha haemoglobin‐stabilising protein concentration in the red blood cells of patients with sickle cell anaemia with and without hydroxycarbamide treatment. British Journal of Haematology. 196(1). 183–192. 1 indexed citations
5.
Tamagne, Marie, Sadaf Pakdaman, Pablo Bartolucci, et al.. (2021). Whole-blood phenotyping to assess alloimmunization status in transfused sickle cell disease patients. Blood Advances. 5(5). 1278–1282. 10 indexed citations
6.
Hebert, Nicolas, Gwellaouen Bodivit, Étienne Audureau, et al.. (2020). Individual red blood cell fetal hemoglobin quantification allows to determine protective thresholds in sickle cell disease. American Journal of Hematology. 95(11). 1235–1245. 16 indexed citations
7.
Chadebech, Philippe, Gwellaouen Bodivit, Sadaf Pakdaman, et al.. (2020). Cytokine changes in sickle-cell disease patients as markers predictive of the onset of delayed hemolytic transfusion reactions. Cytokine. 136. 155259–155259. 3 indexed citations
8.
Roumenina, Lubka T., Philippe Chadebech, Gwellaouen Bodivit, et al.. (2020). Complement activation in sickle cell disease: Dependence on cell density, hemolysis and modulation by hydroxyurea therapy. American Journal of Hematology. 95(5). 456–464. 53 indexed citations
9.
Morel, Alexandre, Slimane Allali, Maximilien Grall, et al.. (2019). Treatment of Delayed Hemolytic Transfusion Reactions in Sickle Cell Disease Patients By an Anti-C5 Antibody. Blood. 134(Supplement_1). 2458–2458. 2 indexed citations
10.
Bodivit, Gwellaouen, Roberta Foresti, Laurent Kiger, et al.. (2018). Protective Effects of Carbon Monoxide Delivered By Corm-401 in Hyperhemolysis in Patients with Sickle Cell Disease. Blood. 132(Supplement 1). 2367–2367. 1 indexed citations
11.
Meinderts, Sanne M., Karin Fijnvandraat, Sietse Q. Nagelkerke, et al.. (2017). Nonclassical FCGR2C haplotype is associated with protection from red blood cell alloimmunization in sickle cell disease. Blood. 130(19). 2121–2130. 26 indexed citations
12.
Chadebech, Philippe, Gwellaouen Bodivit, Armand Mekontso Dessap, et al.. (2016). Evidence of benefits from using fresh and cryopreserved blood to transfuse patients with acute sickle cell disease. Transfusion. 56(7). 1730–1738. 13 indexed citations
13.
Vingert, Benoît, Marie Tamagne, Anoosha Habibi, et al.. (2015). Phenotypic differences of CD4+ T cells in response to red blood cell immunization in transfused sickle cell disease patients. European Journal of Immunology. 45(6). 1868–1879. 44 indexed citations
14.
Vingert, Benoît, Marie Tamagne, Maxime Desmarets, et al.. (2013). Partial dysfunction of Treg activation in sickle cell disease. American Journal of Hematology. 89(3). 261–266. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026